UNICREDIT BANK/CALL/BIOGEN IDEC/220/0.1/15.01.25 Share Price

Warrant

DE000HD31TH4

Real-time BOERSE MUENCHEN 03:11:17 02/07/2024 pm IST
3.04 EUR -0.98% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/220/0.1/15.01.25
Current month+4.78%
1 month+8.87%
Date Price Change
02/24/02 3.04 -0.98%
01/24/01 3.07 +4.78%
28/24/28 2.93 +0.69%
27/24/27 2.91 +11.49%
26/24/26 2.61 +0.77%

Real-time BOERSE MUENCHEN

Last update July 02, 2024 at 03:11 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD31TH
ISINDE000HD31TH4
Date issued 26/02/2024
Strike 220 $
Maturity 15/01/2025 (198 Days)
Parity 10 : 1
Emission price 3.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.52
Lowest since issue 1.47
Delta0.68x
Omega 4.852
Premium8.84x
Gearing7.19x
Moneyness 1.054
Difference Strike -11.77 $
Difference Strike %-5.35%
Spread 0.06
Spread %1.97%
Theoretical value 3.020
Implied Volatility 33.91 %
Total Loss Probability 41.91 %
Intrinsic value 1.098
Present value 1.922
Break even 252.36 €
Theta-0.05x
Vega0.06x
Rho0.06x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8 USD
Average target price
283.2 USD
Spread / Average Target
+22.17%
Consensus